Status:
COMPLETED
Epidemiological Features and Clinical Course of COVID -19 Infection in Cancer Patients: The Rovid Study
Lead Sponsor:
Istituto Oncologico Veneto IRCCS
Conditions:
Solid Tumor, Adult
Eligibility:
All Genders
18-65 years
Brief Summary
The study aims to retrospectively collect epidemiological and clinical data in patients with solid tumors and SARS Covid2 infections belonging to oncology centers within the Veneto Oncology Network
Detailed Description
The aim of this study is to create a Veneto Oncology Network with the aim of collecting clinical and epidemiological data of cancer Patients affected by SAR- Covid-2 infection over a period of 1 year....
Eligibility Criteria
Inclusion
- be 18 Years and older
- cancer patients belonging to Veneto 's Oncological Network
- Patients with SAR COV-2 infection
Exclusion
- Patients with no SAR COV2 Infection
- Volunteers
- No Cancer Patients
Key Trial Info
Start Date :
June 4 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 4 2021
Estimated Enrollment :
761 Patients enrolled
Trial Details
Trial ID
NCT04811781
Start Date
June 4 2020
End Date
June 4 2021
Last Update
November 1 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
istituto Oncologico Veneto -UOSD Melanoma
Padua, PD, Italy
2
Aulss1 Dolomiti
Belluno, Italy
3
Istituto Oncologico Veneto -UOC Oncologia 1
Padua, Italy